Progression-free survival on endocrine therapy, before or after chemotherapy, in hormone receptor-positive HER2-negative metastatic breast cancer.

Pauline CorbauxAudrey Lardy-CleaudMarie AlexandreMaxime FontanillesChristelle LévyAlessandro Adriano ViansoneAudrey MailliezMarc DebledAnthony GoncalvesFanny Le DuFlorence LereboursJean-Marc FerreroJean-Christophe EymardMarie-Ange Mouret-ReynierThierry PetitJean-Sébastien FrenelFlorence DalencCoralie CourtinardMarie ChaixThomas Bachelot

Published in: Breast cancer research and treatment (2021)

PFS under first ET appears identical whether prescribed before or after chemotherapy. These data suggest chemotherapy does not promote endocrine resistance.

Keyphrases

free survival
metastatic breast cancer
locally advanced
squamous cell carcinoma
rectal cancer
electronic health record
chemotherapy induced
radiation therapy
machine learning
mesenchymal stem cells
cell therapy